Clinical Trial Update: Matrix Metalloproteinases in Patients With Critical Limb Ischemia Undergoing Surgical Revascularization [NA]

View source ↗

Summary

A completed clinical trial evaluated matrix metalloproteinases in patients with critical limb ischemia undergoing surgical revascularization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Snippet

Sponsor: University of Catanzaro | Conditions: Critical Limb Ischemia, Extracellular Matrix Alteration | NA | Status: COMPLETED